Unknown

Dataset Information

0

Highly Pathogenic Avian Influenza H5 Hemagglutinin Fused with the A Subunit of Type IIb Escherichia coli Heat Labile Enterotoxin Elicited Protective Immunity and Neutralization by Intranasal Immunization in Mouse and Chicken Models.


ABSTRACT: Highly pathogenic avian influenza viruses are classified by the World Organization for Animal Health (OIE) as causes of devastating avian diseases. This study aimed to develop type IIb Escherichia coli heat-labile enterotoxin (LTIIb) as novel mucosal adjuvants for mucosal vaccine development. The fusion protein of H5 and LTIIb-A subunit was expressed and purified for mouse and chicken intranasal immunizations. Intranasal immunization with the H5-LTIIb-A fusion protein in mice elicited potent neutralizing antibodies in sera and bronchoalveolar lavage fluids, induced stronger Th1 and Th17 cellular responses in spleen and cervical lymph nodes, and improved protection against H5N1 influenza virus challenge. More interestingly, intranasal immunization with the H5-LTIIb-A fusion protein in chickens elicited high titers of IgY, IgA, hemagglutinin inhibition (HAI), and neutralizing antibodies in their antisera. This study employed the novel adjuvants of LTIIb for the development of a new generation of mucosal vaccines against highly pathogenic avian influenza viruses.

SUBMITTER: Tang N 

PROVIDER: S-EPMC6963717 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Highly Pathogenic Avian Influenza H5 Hemagglutinin Fused with the A Subunit of Type IIb <i>Escherichia coli</i> Heat Labile Enterotoxin Elicited Protective Immunity and Neutralization by Intranasal Immunization in Mouse and Chicken Models.

Tang Neos N   Lin Shi-Wei SW   Chen Ting-Hsuan TH   Jan Jia-Tsrong JT   Wu Hung-Yi HY   Wu Suh-Chin SC  

Vaccines 20191122 4


Highly pathogenic avian influenza viruses are classified by the World Organization for Animal Health (OIE) as causes of devastating avian diseases. This study aimed to develop type IIb <i>Escherichia</i> <i>coli</i> heat-labile enterotoxin (LTIIb) as novel mucosal adjuvants for mucosal vaccine development. The fusion protein of H5 and LTIIb-A subunit was expressed and purified for mouse and chicken intranasal immunizations. Intranasal immunization with the H5-LTIIb-A fusion protein in mice elici  ...[more]

Similar Datasets

| S-EPMC2367145 | biostudies-other
| S-EPMC8623123 | biostudies-literature
| S-EPMC9040744 | biostudies-literature
| S-EPMC8122160 | biostudies-literature
| S-EPMC7768441 | biostudies-literature
| S-EPMC3371729 | biostudies-literature
| S-EPMC6863725 | biostudies-literature
| S-EPMC3153253 | biostudies-literature
| S-EPMC3592130 | biostudies-literature
| S-EPMC3745432 | biostudies-literature